Michael Nall Email & Phone Number

Michael Nall is a CEO and Board Member at Exai Bio. He possess expertise in biotechnology, medical devices, managed care, oncology, product launch and 14 more skills. Colleagues describe him as "It’s rare that you come across standout talent like Mike. I’ve had the pleasure of reporting to and working with Mike for over five years while at Biocept. Always open and respectful of others and their opinions, we’ve collaborated on many topics and challenges, taking action that led to solutions. Above all, I’m impressed with Mike’s broad knowledge of healthcare, his vision and leadership. Mike’s smart, organized, has a cheerful disposition, friendly smile and is wonderful to work with. I’ve always been in awe of Mike’s ability to command a room whether at an employee Town Hall meeting, Investor conference or Investor presentation. As a Team Member or a Leader, Mike earns my highest recommendation.", "Mike is an outstanding leader and strategic thinker. His ability to listen, adapt are some of his strongest attributes. He has great breadth of diagnostics knowledge, with strong managed care expertise too. He is consummate teacher and he does it with humility and passion. His teams are always high achievers and well respected. He lives a brand of integrity and creativity.", and "Mike is a very ambitious, hard working, detail oriented and committed executive leader. With his tremendous knowledge in laboratory diagnostics, Mike is an asset to any corporation that markets laboratory diagnostic products and services. As a Manager and leader of the company, Mike is fair but expects results. He will help anyone through a problem and is first to celebrate your success. I appreciated Mike's willingness to listen to whatever strategy I presented and challenged me with the hard questions that needed to be asked. Mike is a team player and has the ability to accelerate any company's growth plan. Any Executive team would be lucky to have Mike to assist in leading their organization."

Listed skills include Biotechnology, Medical Devices, Managed Care, Oncology, and 15 others.